Universal Health: JP Morgan maintains a 'Neutral' Rating, The Target Price is $195

JP Morgan maintains 'Neutral' rating on Universal Health(UHS).

The target price is $195, compare with $215 previously.

[Recent Rating]

Date	Agency	Change	Rating	Rating （previously）	Target Price	Target Price（previously）
2025-08-04	JP Morgan	Maintains	Neutral	Neutral	$195	$215
2025-07-30	Barclays	Maintains	Overweight	Overweight	$259	$257
2025-07-16	B of A Securities	Downgrades	Underperform	Neutral	$185	$215

[Recent Earning Results] Universal Health posted the Q2 of its 2025 financial results on 7/28/2025, reporting total revenue of USD 8383.54 million in the first half of the year, up 8.16% from USD 7751.19 million year over year, reporting net income of USD 684.24 million in the first half of the year, up 22.15% from USD 560.15 million year over year.

[Company Profile] Universal Health Services, Inc. is a Delaware corporation that was organized in 1979. The company principal business is owning and operating, through subsidiaries, acute care hospitals and outpatient facilities and behavioral health care facilities. Services provided by hospitals include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and behavioral health services. The company provide capital resources as well as a variety of management services to facilities, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment services, administrative personnel management, marketing and public relations.